Trial
NCT05498545
Universal BCMA-targeted LUCAR-B68 Cells in Patients With Relapsed/Refractory Multiple Myeloma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University
Collaborators
Nanjing Legend Biotech Co.
Condition
Relapsed/Refractory Multiple Myeloma
Intervention
LUCAR-B68 cells product
Why stopped
Achieved the proof of concept
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-16